PT2841426T - Derivados de quinolina antibacterianos - Google Patents

Derivados de quinolina antibacterianos

Info

Publication number
PT2841426T
PT2841426T PT137208757T PT13720875T PT2841426T PT 2841426 T PT2841426 T PT 2841426T PT 137208757 T PT137208757 T PT 137208757T PT 13720875 T PT13720875 T PT 13720875T PT 2841426 T PT2841426 T PT 2841426T
Authority
PT
Portugal
Prior art keywords
quinoline derivatives
antibacterial quinoline
antibacterial
derivatives
quinoline
Prior art date
Application number
PT137208757T
Other languages
English (en)
Portuguese (pt)
Inventor
Emile Georges Guillemont Jerôme
Madeleine Simone Motte Magali
Francis Alain Lançois David
Mia Albert Balemans Wendy
Robert Gaston Thomas Sébastien
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT2841426T publication Critical patent/PT2841426T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT137208757T 2012-04-27 2013-04-26 Derivados de quinolina antibacterianos PT2841426T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12165882 2012-04-27

Publications (1)

Publication Number Publication Date
PT2841426T true PT2841426T (pt) 2016-11-23

Family

ID=48325651

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137208757T PT2841426T (pt) 2012-04-27 2013-04-26 Derivados de quinolina antibacterianos

Country Status (15)

Country Link
US (1) US9617244B2 (enExample)
EP (1) EP2841426B1 (enExample)
JP (1) JP6153603B2 (enExample)
KR (1) KR102110366B1 (enExample)
CN (1) CN104254528B (enExample)
AU (1) AU2013254670B2 (enExample)
CA (1) CA2869453C (enExample)
DK (1) DK2841426T3 (enExample)
EA (1) EA038350B1 (enExample)
ES (1) ES2607879T3 (enExample)
IN (1) IN2014MN02358A (enExample)
MX (1) MX358506B (enExample)
PL (1) PL2841426T3 (enExample)
PT (1) PT2841426T (enExample)
WO (1) WO2013160431A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133167B2 (en) * 2012-04-27 2015-09-15 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
US11857352B2 (en) 2016-09-06 2024-01-02 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection
EP4493551A1 (en) 2022-03-14 2025-01-22 Slap Pharmaceuticals LLC Multicyclic compounds

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018326A1 (en) 1996-10-28 1998-05-07 Department Of The Army, U.S. Government Compounds, compositions and methods for treating antibiotic-resistant infections
US6103905A (en) 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
MXPA05001052A (es) 2002-07-25 2005-04-08 Janssen Pharmaceutica Nv Derivados de quinolina y su uso como inhibidores micobacterianos.
US7902225B2 (en) 2004-01-23 2011-03-08 Janssen Pharmaceutica Nv Mycobacterial inhibitors
EA011359B1 (ru) * 2004-01-23 2009-02-27 Янссен Фармацевтика Н.В. Замещенные хинолины и их применение в качестве микобактериальных ингибиторов
EP1713776B1 (en) 2004-01-29 2008-05-14 Janssen Pharmaceutica N.V. Quinoline derivatives for use as mycobacterial inhibitors
EA010651B1 (ru) 2004-05-28 2008-10-30 Янссен Фармацевтика Н.В. Применение замещенных хинолиновых производных для лечения заболеваний, вызываемых микобактериями, резистентными к лекарственным средствам
WO2005123081A2 (en) 2004-06-22 2005-12-29 Janssen Pharmaceutica N.V. (2-benzyl-4-{4-[1-(tetrahydrofuran-3-carbonyl)-pyrrolidin-3-yl]-piperazin-1-yl}-piperidin-1-yl)-(3,5-trifluoromethyl-phenyl))-methanone for the treatment of schizophrenia
PL1797115T3 (pl) 2004-09-28 2017-12-29 Janssen Pharmaceutica N.V. Domena wiążąca bakteryjnej syntazy ATP
EE05394B1 (et) 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
EE05697B1 (et) 2005-06-08 2014-02-17 Janssen Pharmaceutica N.V. Kinoliini derivaadid kui antibakteriaalsed toimeained
JO3270B1 (ar) 2005-06-28 2018-09-16 Janssen Pharmaceutica Nv مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
DK1898909T3 (en) 2005-06-28 2017-02-06 Janssen Pharmaceutica Nv QUINOLIN DERIVATIVES AS ANTIBACTERIAL AGENTS
JO2752B1 (en) 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO3077B1 (ar) 2005-07-28 2017-03-15 Janssen Pharmaceutica Nv مشتقات كوينولين مضادة للبكتيريا
JO2855B1 (en) 2005-08-03 2015-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2952B1 (en) 2005-08-03 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents
JO3271B1 (ar) 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2725B1 (en) * 2006-12-06 2013-09-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2685B1 (en) 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO2684B1 (en) 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
WO2009091324A1 (en) * 2008-01-14 2009-07-23 Jyoti Chattopadhyaya Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents
US9133167B2 (en) * 2012-04-27 2015-09-15 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives

Also Published As

Publication number Publication date
KR102110366B1 (ko) 2020-05-14
CN104254528A (zh) 2014-12-31
DK2841426T3 (en) 2017-01-09
MX358506B (es) 2018-08-22
MX2014013055A (es) 2014-12-10
AU2013254670A1 (en) 2014-10-16
PL2841426T3 (pl) 2017-03-31
EP2841426B1 (en) 2016-09-28
IN2014MN02358A (enExample) 2015-08-14
KR20150013148A (ko) 2015-02-04
CA2869453C (en) 2021-03-02
CN104254528B (zh) 2017-06-06
US20150051244A1 (en) 2015-02-19
ES2607879T3 (es) 2017-04-04
WO2013160431A1 (en) 2013-10-31
US9617244B2 (en) 2017-04-11
EA201491971A1 (ru) 2015-02-27
CA2869453A1 (en) 2013-10-31
EA038350B1 (ru) 2021-08-12
HK1201520A1 (en) 2015-09-04
AU2013254670B2 (en) 2017-03-30
JP2015514795A (ja) 2015-05-21
JP6153603B2 (ja) 2017-06-28
EP2841426A1 (en) 2015-03-04

Similar Documents

Publication Publication Date Title
IL239109A0 (en) State-of-the-art quinolone derivatives
ZA201600514B (en) Quinoline derivative
ZA201409422B (en) Benzimidazole-proline derivatives
ZA201408876B (en) Pyrrolotriazinone derivatives
EP2828257A4 (en) ANTIBACTERIAL COMPOUNDS
IL236295A (en) The history of indanesulfamide
ZA201502175B (en) Oxazolidin-2-one-pyrimidine derivatives
PL2841425T3 (pl) Antybakteryjne pochodne chinoliny
ZA201405108B (en) Substituted phenylazole derivative
GB201206384D0 (en) Antibacterial drug derivatives
PL2873660T3 (pl) Pochodna indolokarboksyamidu
PT2841426T (pt) Derivados de quinolina antibacterianos
ZA201501640B (en) Tricyclic tetrahydroquinoline antibacterial agents
SG11201504873RA (en) Antibacterial compounds
IL239207A0 (en) Antibacterial compounds
GB201206385D0 (en) Antibacterial drug derivatives
GB201206383D0 (en) Antibacterial drug derivatives
GB201119958D0 (en) Antibacterial derivatives
GB201119961D0 (en) Antibacterial derivatives